Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII

Bone Marrow Transplantation

Volumn 25, Issue 12, 2000, Pages 1289-1297

  Sammarco, C ^a   Weil, M ^a   Just, C ^a   Weimelt, S ^a   Hasson, C ^a   O'Malley, T ^a   Evans, S M ^a   Wang, P ^a   Casal, M L ^a   Wolfe, J ^a   Haskins, M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone marrow transplantation; Canine; Cardiovascular; Lysosomal storage; Mucopolysaccharidosis

Indexed keywords

BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA VALVE DISEASE; ARTICLE; AUTOPSY; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CORONARY ARTERY; DOG DISEASE; ELECTROCARDIOGRAM; ELECTRON MICROSCOPY; ENZYME ACTIVITY; LYSOSOME STORAGE DISEASE; MITRAL VALVE DISEASE; MUCOPOLYSACCHARIDOSIS TYPE 7; NONHUMAN; PRIORITY JOURNAL;

EID: 0033934527     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702448     Document Type: Article

References (48)

1. Holtzman E. Storage disease. In: Siekevitz P (ed). Lysosomes. Plenum Press: New York, 1989, pp 344-356.
2. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill: New York, 1995, pp 2465-2508.
3. Haskins ME, Giger U. Lysosomal storage diseases. In: Kaneko JJ, Harvey JW, Bruss ML (eds). Lysosomal Storage Diseases in Clinical Biochemistry of Domestic Animals. Academic Press, New York, 1997, pp 741-761.
4. Giger U, Shivaprasad HL, Wang P et al. Mucopolysaccharidosis IIIB (Sanfilippo B syndrome) in emus. Vet Pathol 1997; 34: 473.
5. Haskins ME, Desnick RJ, DiFerrante N et al. Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII. Pediatr Res 1984; 18: 980-984.
6. Schuchman EH, Tordyan TK, Haskins ME, Desnick RJ. Characterization of the defective β-glucuronidase activity in canine mucopolysaccharidosis type VII. Enzyme 1989; 42: 174-180.
7. Sheridan O, Wortman J, Harvey C et al. Craniofacial abnormalities in animal models of mucopolysaccharidoses I, VI, and VII. J Craniofac Genet Dev Biol 1994; 14: 7-15.
8. Ray J, Bouvet A, DeSanto C et al. Cloning of canine β-glucuronidase: identification of a missense mutation in canine mucopolysaccharidosis type VII, and correction of mutant cells by retroviral vector-mediated gene transfer. Genomics 1998; 48: 248-253.
9. Kaplan A, Achord DT, Sly WS. Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc Natl Acad Sci USA 1977; 74: 2026-2030.
10. Distler J, Hieber V, Sahagian G, Schmickel R, Jourdian GW. Identification of mannose 6-phosphate in glycoproteins that inhibit the assimilation of beta-galactosidase by fibroblasts. Proc Natl Acad Sci USA 1979; 76: 4235-4239.
11. Natowicz MR, Chi MM, Lowry OH, Sly WS. Enzymatic identification of mannose 6-phosphate on the recognition marker for receptor-mediated pinocytosis of beta-glucuronidase by human fibroblasts. Proc Natl Acad Sci USA 1979; 76: 4322-4326.
12. Neufeld EF, Fratantoni JC. Inborn errors of mucopolysaccharide metabolism. Science 1970; 169: 141-146.
13. Wolfe JH, Sands MS, Barker JE et al. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 1992; 360: 749-753.
14. Wolfe JH, Haskins ME, Zmijewski CM. Mixed lymphocyte reactivity in cats. Transplantation 1984; 37: 509-513.
15. Spurr AR. A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 1969; 26: 31-43.
16. Reynolds E. The use of lead citrate at a high pH as an electronopague stain in electron microscopy. J Cell Biol 1963; 17: 209-212.
17. Sheehan DC, Hrapchak BB. Instrumentation. In: Theory and Practice of Histotechnology. CV Mosby: St Louis, 1980, pp 17, 296, 298-299, 301.
18. Wolfe JH, Sands MS. Murine mucopolysaccaridosis type VII: a model system for somatic gene therapy of the central nervous system. In: Lowenstein PR, Enquist LW (eds). Protocols for gene transfer in neuroscience: towards gene therapy of neurological disorders. John Wiley: Chichester, 1996, pp 265-274.
19. Okada S, O'Brien JS. Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component. Science 1969; 165: 698-700.
20. Bjornsson S. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem 1993; 210: 282-291.
21. O'Grady MR, Bonagura JD, Powers JD, Herring DS. Quantitative cross-sectional echocardiography in the normal dog. Vet Radiol 1986; 27: 34-49.
22. Haskins ME, Aguirre GD, Jezyk PF, Patterson DF. The pathology of feline arylsulfatase B-deficient mucopolysaccharidosis. Am J Pathol 1980; 101: 657-674.
23. Haskins ME, Aguirre GD, Jezyk PF et al. The pathology of feline alpha-L-iduronidase deficient mucopolysaccharidosis. Am J Pathol 1983; 112: 27-36.
24. Shull RM, Helman RG, Spellacy E et al. Morphologic and biochemical studies of canine mucopolysaccharidosis I. Am J Pathol 1984; 114: 487-495.
25. Yoshida M, Ikadai H, Maekawa A et al. Pathological characteristics of mucopolysaccharidosis VI in the rat. J Comp Pathol 1993; 109: 141-153.
26. Krovetz LJ, Lorincz AE, Schiebler GL. Cardiovascular manifestations of the Hurler sundrome: cardiovascular and angiocardiographic observations in 15 patients. Circulation 1965; 31: 132-141.
27. Krovetz, LJ, Schiebler GL. Cardiovascular manifestations of the genetic mucopolysaccharidoses. Birth Defects 1972; 8: 192-196.
28. Schicken RM, Kerber RE, Ionasescu VV, Zellweger H. Cardiac manifestations of the mucopolysaccharidoses. Circulation 1975; 52: 700-705.
29. Renteria VG, Ferrans VJ, Roberts WC. The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases. Am J Cardiol 1976; 38: 487-501.
30. Wilson CS, Mankin HT, Pluth JR. Aortic stenosis and mucopolysaccharidosis. Annal Int Med 1980; 92: 496-498.
31. Brosius FC, Roberts WC. Coronary artery disease in the Hurler syndrome. Qualitative and quantitative analysis of the extent of coronary narrowing at necropsy in six children. Am J Cardiol 1981; 47: 649-653.
32. Johnson GL, Vine DL, Cottrill CM, Noonan JA. Echocardiographic mitral valve deformity in the mucopolysaccharidoses. Pediatrics 1981; 67: 401-406.
33. Gross DM, Williams JC, Caprioli C et al. Echocardiographic abnormalities in the mucopolysaccharide storage diseases. Am J Cardiol 1988; 61: 170-176.
34. Nelson J, Shields MD, Mulholland HC. Cardiovascular studies in the mucopolysaccharidoses. J Med Genet 1990; 27: 94-100.
35. John RM, Hunter D, Swanton RH. Echocardiographic abnormalities in type IV mucopolysaccharidosis. Arch Dis Child 1990; 65: 746-749.
36. Vinallonga X, Sanz N, Balaguer A et al. Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone marrow transplantation. Pediatr Cardiol 1992; 13: 107-109.
37. Braunlin EA, Hunter DW, Krivit W et al. Evaluation of coronary artery disease in the Hurler syndrome by angiography. Am J Cardiol 1992; 69: 1487-1489.
38. DuCret RP, Weinberg EJ, Jackson CA et al. Resting TI-201 scintigraphy in the evaluation of coronary artery disease in children with Hurler syndrome. Clin Nucl Med 1994; 19: 975-978.
39. Gatzoulis MA, Vellodi A, Redington AN. Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation. Arch Dis Child 1995; 73: 259-260.
40. Wippermann CF, Beck M, Schranz D et al. Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Euro J Pediatr 1995; 154: 98-101.
41. Yamada Y, Kato K, Sukegawa S et al. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant 1998; 21: 629-634.
42. Brieder MA, Schull RM, Constantopoulos G. Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I. Am J Pathol 1989; 134: 677-692.
43. Gompf RE, Schull RM, Breider MA et al. Cardiovascular changes after bone marrow transplantation in dogs with mucopolysaccharidosis I. Am J Vet Res 1990; 51: 2054-2060.
44. Birkenmeier EH, Barker JE, Vogler C et al. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 1991; 78: 3081-3092.
45. Sands MS, Barker JE, Vogler C et al. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest 1993; 68: 676-686.
46. Poorthuis BJHM, Romme AE, Willemsen R, Wagemaker G. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocyes of mycopolysaccharidosis type VII mice. Pediatr Res 1994; 36: 187-193.
47. Sands MS, Vogler C, Kyle JW et al. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J Clin Invest 1994; 93: 2324-2331.
48. Daly TM, Vogler C, Levy B et al. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci USA 1999; 96: 2296-2300.